Faces of Leadership in Diagnostics: Bonnie Anderson, Veracyte


Guest:

Bonnie Anderson, CEO, Veracyte Bio and Contact Info

Listen (5:58) What is the secret to your success?

Listen (4:30) Building the case for reimbursement

Listen (5:14) How did you go about finding a commercially viable pathway?

Listen (6:03) Challenges to adoption

Listen (2:27) What are you anticipating on the regulatory front?

Listen (6:41) A woman of influence

Today we’re pleased to launch a new series, Faces of Leadership in Diagnostics, underwritten by the executive recruitment firm, Slone Partners.

We begin with the leader of a company that has been going from one giant success to another. Bonnie Anderson is the CEO of Veracyte. She has been awarded the “Women of Influence” award by Silicon Valley Business Journal and named one of the best Bay Area Life Science CEO’s by the San Francisco Business Times.

In 2013, Bonnie led Veracyte through a successful IPO, and this year the company has won contracts with two major payers, United Healthcare and Cigna, for their breakthrough Afirma Thyroid Analysis test. This gene expression based test is saving thousands of patients from undergoing unnecessary thyroid surgeries.

In today’s interview, Bonnie explains the secret to her success at Veracyte. Rather than beginning as a company with a cool technology, Bonnie says they started by looking for a clinical area where there was a huge unmet need.

"What we realized early on, was that the science is so rich today, and the tools available just keep getting better,” she says. “The assumption we made was that we would be able to figure out the scientific answer. But the challenge was in finding the commercially viable pathway where we could start, and then have a runway of expanding that same strategy across many indications so we could build a scalable, viable company."

Advertisement:

Easier said than done. We ask Bonnie just how she and her team went about finding that “commercially viable pathway.”

Bonnie is a co-founder of the company, coming out of retirement after an already successful career in diagnostics. She explains her leadership style and describes the unique company culture she has fostered at Veracyte that has made the company a shining beacon in the tough space of diagnostics.

Podcast brought to you by: Slone Partners - Premier talent. Delivered.



New to Mendelspod?

We advance life science research, connecting people and ideas.
Register here to receive our newsletter.

or skip signup